Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
or

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
21.87 +1.42 (+6.94%) 04/22/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 21.87 unch (unch) 16:02 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
20.37
Day High
21.95
Open 20.78
Previous Close 20.45 20.45
Volume 282,000 282,000
Avg Vol 431,665 431,665
Stochastic %K 94.39% 94.39%
Weighted Alpha -11.88 -11.88
5-Day Change +3.16 (+16.89%) +3.16 (+16.89%)
52-Week Range 13.36 - 32.27 13.36 - 32.27
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 656,977
  • Shares Outstanding, K 32,126
  • Annual Sales, $ 6,240 K
  • Annual Income, $ -84,970 K
  • EBIT $ -102 M
  • EBITDA $ -107 M
  • 60-Month Beta 1.62
  • Price/Sales 100.47
  • Price/Cash Flow N/A
  • Price/Book 1.64

Options Overview Details

View History
  • Implied Volatility 102.26% ( -4.15%)
  • Historical Volatility 86.22%
  • IV Percentile 45%
  • IV Rank 32.52%
  • IV High 149.03% on 04/08/25
  • IV Low 79.73% on 10/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 6
  • Volume Avg (30-Day) 50
  • Put/Call OI Ratio 0.88
  • Today's Open Interest 850
  • Open Int (30-Day) 893

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -0.86
  • Number of Estimates 6
  • High Estimate -0.74
  • Low Estimate -1.03
  • Prior Year -0.54
  • Growth Rate Est. (year over year) -59.26%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.36 +63.64%
on 04/09/25
Period Open: 19.49
21.95 -0.36%
on 04/22/25
+2.38 (+12.21%)
since 03/21/25
3-Month
13.36 +63.64%
on 04/09/25
Period Open: 22.66
25.45 -14.08%
on 02/14/25
-0.79 (-3.49%)
since 01/22/25
52-Week
13.36 +63.64%
on 04/09/25
Period Open: 23.24
32.27 -32.23%
on 11/08/24
-1.37 (-5.90%)
since 04/22/24

Most Recent Stories

More News
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences

DNTH : 21.87 (+6.94%)
Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting

DNTH : 21.87 (+6.94%)
The Future of Medicine: Drug Delivery Innovations Leading a $700 Billion Market

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – In the field of medicine, many...

BVAXF : 0.0301 (+10.66%)
BIOV.CN : 0.0400 (+14.29%)
LEXX : 1.4600 (+5.04%)
TFFP : 0.0650 (-60.05%)
DNTH : 21.87 (+6.94%)
AQST : 2.75 (+6.59%)

Business Summary

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 24.00
2nd Resistance Point 22.98
1st Resistance Point 22.42
Last Price 21.87
1st Support Level 20.84
2nd Support Level 19.82
3rd Support Level 19.26

See More

52-Week High 32.27
Fibonacci 61.8% 25.05
Fibonacci 50% 22.82
Last Price 21.87
Fibonacci 38.2% 20.59
52-Week Low 13.36

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro